Recently, one study has identified 13 highly predictive biomarkers of metastatic risk of NPC, including WSB2, FNDC3B and CXCL10, and consolidated the clinical utility of these biomarkers in 937 patients in Southern China (Tang et al., 2018). This evidence concerns the gene CXCL10 and nasopharyngeal carcinoma.